University of Oxford

- Country
- π¬π§United Kingdom
- Ownership
- Private
- Established
- 1096-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.ox.ac.uk
T-Cell Turnover Following Vaccination With MVA85A
- Conditions
- Tuberculosis
- First Posted Date
- 2007-10-24
- Last Posted Date
- 2010-01-18
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 12
- Registration Number
- NCT00548444
- Locations
- π¬π§
University of Oxford, Oxford, Oxfordshire, United Kingdom
Clinical Investigation of In-vivo Susceptibility of P.Falciparum to Artesunate in Western Cambodia
- Conditions
- Falciparum Malaria
- Interventions
- First Posted Date
- 2007-06-28
- Last Posted Date
- 2018-05-04
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 40
- Registration Number
- NCT00493363
- Locations
- π°π
Pailin Referal Hospital, Pailin, Cambodia
Safety, Immunogenicity, and Impact of MVA85A, on the Immunogenicity of the EPI Vaccines
- Conditions
- TB
- First Posted Date
- 2007-05-31
- Last Posted Date
- 2010-02-09
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 214
- Registration Number
- NCT00480454
- Locations
- π¬π²
MRC, Banjul, Gambia
A Study of the Immunogenicity of M. Bovis BCG, Delivered Intradermally in Healthy Volunteers
- Conditions
- TB
- First Posted Date
- 2007-05-31
- Last Posted Date
- 2007-05-31
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 11
- Registration Number
- NCT00480688
- Locations
- π¬π§
University of Oxford, CCVTM, Churchill Hospital, Oxford, Oxfordshire, United Kingdom
A Study of the Immunogenicity of BCG, Delivered Intradermally in Healthy Volunteers
- Conditions
- TB
- First Posted Date
- 2007-05-31
- Last Posted Date
- 2007-05-31
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 10
- Registration Number
- NCT00480714
- Locations
- π¬π§
University of Oxford, CCVTM, Churchill Hospital, Oxford, Oxfordshire, United Kingdom
A Study of MVA85A, in Asymptomatic Volunteers Infected With TB, HIV or Both
- Conditions
- HIV InfectionsTB
- First Posted Date
- 2007-05-31
- Last Posted Date
- 2011-03-28
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 48
- Registration Number
- NCT00480558
- Locations
- πΏπ¦
University Cape Town, Cape Town, South Africa
A Study of 2 Doses of a New TB Vaccine, MVA85A, in Healthy Volunteers Previously Vaccinated With BCG
- Conditions
- Tuberculosis
- First Posted Date
- 2007-04-25
- Last Posted Date
- 2008-04-04
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 24
- Registration Number
- NCT00465465
- Locations
- π¬π§
University of Oxford, CCVTM, Churchill Hospital, Oxford, Oxfordshire, United Kingdom
Treatment of HDL to Reduce the Incidence of Vascular Events HPS2-THRIVE
- Conditions
- Cardiovascular DiseasePeripheral Arterial DiseaseDiabetes MellitusCoronary Heart Disease
- Interventions
- First Posted Date
- 2007-04-18
- Last Posted Date
- 2014-02-28
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 25673
- Registration Number
- NCT00461630
- Locations
- π¬π§
Clinical Trial Service Unit, University of Oxford, Oxford, United Kingdom
The Effectiveness of Supported Employment for People With Severe Mental Illness: an RCT in Six European Countries
- Conditions
- Psychosis
- First Posted Date
- 2007-04-18
- Last Posted Date
- 2007-04-18
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 300
- Registration Number
- NCT00461318
- Locations
- π¬π§
Division of mental health, St Georges medical school, university of london, London, United Kingdom
Safety and Immunogenicity of MVA85A, in Healthy Volunteers in Cape Town
- Conditions
- Tuberculosis
- First Posted Date
- 2007-04-16
- Last Posted Date
- 2008-08-07
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 36
- Registration Number
- NCT00460590
- Locations
- πΏπ¦
University Cape Town, Cape Town, South Africa